FDA. “FDA” shall mean the United States Food and Drug Administration, or a successor agency thereto.
Appears in 3 contracts
Samples: License Agreement (Discovery Partners International Inc), License Agreement (Infinity Pharmaceuticals, Inc.), License Agreement (Discovery Partners International Inc)
FDA. The term “FDA” shall mean the United States Food and Drug AdministrationAdministration or any successor entity thereto, or a successor agency theretoand any similar Governmental Authority outside of the United States.
Appears in 3 contracts
Samples: Technology License and Services Agreement (Synaptogenix, Inc.), Technology License and Services Agreement (Neurotrope, Inc.), Technology License and Services Agreement (Neurotrope, Inc.)
FDA. “FDA” shall mean means the United States Food and Drug Administration, or a and any successor agency theretoof the United States government.
Appears in 2 contracts
Samples: Three Way Agreement, Three Way Agreement (Nabriva Therapeutics PLC)
FDA. The term “FDA” shall mean the United States Food and Drug Administration, Administration of the United States of America and any successor agency(ies) or a successor agency theretoauthority having substantially the same function.
Appears in 2 contracts
Samples: Option and License Agreement (Magenta Therapeutics, Inc.), Option and License Agreement (Magenta Therapeutics, Inc.)
FDA. “FDA” shall mean the means United States Food and Drug Administration, Administration or a any successor agency theretoagency.
Appears in 2 contracts
Samples: Agreement and Plan of Merger (RayzeBio, Inc.), Agreement and Plan of Merger (Turning Point Therapeutics, Inc.)
FDA. The term “FDA” shall mean the United States Food and Drug Administration, or a any successor agency thereto, having the administrative authority to regulate the marketing of human pharmaceutical products or biological therapeutic products, delivery systems and devices in the United States of America.
Appears in 2 contracts
Samples: Research Funding and Option Agreement (aTYR PHARMA INC), Research Funding and Option Agreement (aTYR PHARMA INC)
FDA. “FDA” shall mean FDA means the United States Food and Drug Administration, or a any successor agency theretowith similar responsibilities.
Appears in 1 contract
FDA. “FDA” shall mean means the Food and Drug Administration of the United States Food Department of Health and Drug Administration, Human Services or a any successor agency thereto.
Appears in 1 contract
FDA. “FDA” shall mean means the Food and Drug Administration of the United States Food Department of Health and Drug AdministrationHuman Services, or a any successor agency thereto.
Appears in 1 contract
Samples: Commercial Manufacturing Services Agreement (Heron Therapeutics, Inc. /De/)
FDA. “The term "FDA” " shall mean the United States Food and Drug Administration, or a any successor agency thereto.
Appears in 1 contract
Samples: License and Sub License Agreement (Bioenvision Inc)
FDA. “The term "FDA” " shall mean the United States Food and Drug Administration, Administration or a any successor agency theretohaving the administrative authority to regulate the approval for testing or marketing of human pharmaceutical, biological medical or medical device products in the United States (or, where appropriate, the equivalent governmental authority in any foreign country).
Appears in 1 contract
Samples: Strategic Alliance Agreement (Miravant Medical Technologies)
FDA. “The term "FDA” " shall mean the United States Food and Drug Administration, Administration or a any successor agency theretohaving the administrative authority to regulate the approval for testing or marketing of human pharmaceutical, biological, medical or medical device products in the United States (or, where appropriate, the equivalent governmental authority in any other country).
Appears in 1 contract
FDA. “FDA” shall mean the United States Food and Drug Administration, or a any successor agency thereto.
Appears in 1 contract
FDA. The term “FDA” shall mean means the United States Food and & Drug AdministrationAdministration and, or a successor when appropriate herein, shall also mean any corresponding regulatory agency theretoin any country.
Appears in 1 contract
Samples: Licensing, Development and Marketing Agreement (Alliance Pharmaceutical Corp)
FDA. “The term "FDA” shall mean " means the United States Food and Drug AdministrationAdministration or any successor entity thereto, or a successor agency theretoincluding its Center for Biologics Evaluation and Research (CBER).
Appears in 1 contract
FDA. The term “FDA” shall mean the United States Food and Drug Administration, or a any successor agency thereto.
Appears in 1 contract
FDA. “FDA” " shall mean the United States Food and Drug AdministrationAdministration or the equivalent governmental authority in any other country, or a any successor agency theretohaving the administrative authority to regulate the approval for testing or marketing of human pharmaceutical or biological medical products and/or medical devices.
Appears in 1 contract
Samples: Development and License Agreement (Miravant Medical Technologies)
